Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
TNF, acting through p55 tumor necrosis factor receptor 1 (TNFR1), contributes to the pathogenesis of many inflammatory diseases. TNFR-associated periodic syndrome (TRAPS, OMIM 142680) is an autosomal dominant autoinflammatory disorder characterized by prolonged attacks of fevers, peritonitis, and soft tissue inflammation. TRAPS is caused by missense mutations in the extracellular domain of TNFR1 that affect receptor folding and trafficking. These mutations lead to loss of normal function rather than gain of function, and thus the pathogenesis of TRAPS is an enigma. Here we show that mutant TNFR1 accumulates intracellularly in peripheral blood mononuclear cells of TRAPS patients and in multiple cell types from two independent lines of knockin mice harboring TRAPS-associated TNFR1 mutations. Mutant TNFR1 did not function as a surface receptor for TNF but rather enhanced activation of MAPKs and secretion of proinflammatory cytokines upon stimulation with LPS. Enhanced inflammation depended on autocrine TNF secretion and WT TNFR1 in mouse and human myeloid cells but not in fibroblasts. Heterozygous TNFR1-mutant mice were hypersensitive to LPS-induced septic shock, whereas homozygous TNFR1-mutant mice resembled TNFR1-deficient mice and were resistant to septic shock. Thus WT and mutant TNFR1 act in concert from distinct cellular locations to potentiate inflammation in TRAPS. These findings establish a mechanism of pathogenesis in autosomal dominant diseases where full expression of the disease phenotype depends on functional cooperation between WT and mutant proteins and also may explain partial responses of TRAPS patients to TNF blockade.
Simon
Anna
A
Inflammatory Biology Section, Laboratory of Clinical Investigation and Immunoregulation Section, Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Park
Heiyoung
H
Maddipati
Ravikanth
R
Lobito
Adrian A
AA
Bulua
Ariel C
AC
Jackson
Adrianna J
AJ
Chae
Jae Jin
JJ
Ettinger
Rachel
R
de Koning
Heleen D
HD
Cruz
Anthony C
AC
Kastner
Daniel L
DL
Komarow
Hirsh
H
Siegel
Richard M
RM
D000818:Animals; D056660:Hereditary Autoinflammatory Diseases / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology; D048670:MAP Kinase Kinase 4 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009154:Mutation; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
D008070:Lipopolysaccharides; D047888:Receptors, Tumor Necrosis Factor, Type I; C506236:Tnfrsf1a protein, mouse; D048051:p38 Mitogen-Activated Protein Kinases; D048670:MAP Kinase Kinase 4
Shock. 1995 Aug;4(2):89-95
7496903
Blood. 2006 Aug 15;108(4):1320-7
16684962
Science. 2002 May 31;296(5573):1634-5
12040173
Arthritis Rheum. 2007 Aug;56(8):2765-73
17665435
Arthritis Rheum. 2008 Jun;58(6):1823-32
18512793
Eur J Hum Genet. 2005 Apr;13(4):513-5
15586174
Cell. 2003 Jul 25;114(2):181-90
12887920
Rheumatology (Oxford). 2007 Jul;46(7):1211-2
16935919
Rheumatology (Oxford). 2006 Jan;45(1):31-7
16287931
J Immunol. 1998 Jan 15;160(2):943-52
9551933
Arthritis Res Ther. 2007;9(4):217
17666110
J Exp Med. 2001 Jun 4;193(11):1333-40
11390441
Medicine (Baltimore). 2002 Sep;81(5):349-68
12352631
Am J Physiol. 1998 Jul;275(1):R269-77
9688988
Immunology. 2004 Sep;113(1):65-79
15312137
Mol Cell Biol. 2002 Dec;22(24):8571-9
12446776
Arthritis Rheum. 2006 Aug;54(8):2674-87
16871532
N Engl J Med. 2006 Aug 10;355(6):581-92
16899778
Nature. 2006 Mar 9;440(7081):237-41
16407889
Ann Rheum Dis. 2006 Sep;65(9):1158-62
16569687
Cell. 2006 Feb 10;124(3):587-99
16469704
Nature. 1993 Aug 26;364(6440):798-802
8395024
Arthritis Rheum. 2004 Aug;50(8):2651-9
15334481
Cell. 1999 Apr 2;97(1):133-44
10199409
Cell. 2005 Mar 11;120(5):649-61
15766528
PLoS Med. 2006 Aug;3(8):e297
16942393
Cytokine. 2006 Nov;36(3-4):160-6
17207633
Annu Rev Immunol. 2009;27:621-68
19302049
Cytokine. 1998 Nov;10(11):897-903
9878127
J Endotoxin Res. 2004;10(3):147-62
15198850
Hum Mutat. 2004 Sep;24(3):194-8
15300846
Gen Pharmacol. 1996 Sep;27(6):973-7
8909977
J Infect Dis. 1994 Jan;169(1):157-61
8277177
J Exp Med. 2004 Aug 2;200(3):367-76
15289505
Eur J Pediatr. 2005 Jan;164(1):13-6
15549379
Ned Tijdschr Geneeskd. 2007 Apr 7;151(14):836-7; author reply 837
17469326
Neuron. 1997 Feb;18(2):327-38
9052802
J Exp Med. 1995 Feb 1;181(2):607-17
7836916